Nav: Home

Scientists see how a protein preserves vision in a unique group of diabetic patients

July 03, 2019

An analysis of samples obtained from a well-studied cohort of over 1,000 patients affected by type 1 diabetes (T1D) for 50 years or longer has identified a protein that protects against an eye condition called diabetic retinopathy (DR) - one of the most common consequences of diabetes - which impacts most diabetic patients after 20 years of living with the disease. Injecting the protein into rodents blocked DR without causing severe side effects, suggesting that preserving or administering the protein could help avoid debilitating eye damage in diabetic patients. Many patients with long-term diabetes develop eye disorders such as DR, which has become a leading cause of vision loss in developed countries. Interestingly, 35% of these patients never develop severe DR even after decades of being diabetic, suggesting they may harbor protective factors against such complications. To solve this mystery, Hishashi Yokomizo and colleagues turned to the Medalist cohort, a unique group of patients affected by T1D for at least 50 years. They compared protein profiles in the retina or vitreous fluid from a total of 43 deceased Medalist patients with either severe or no-to-mild DR, 21 non-Medalist patients with diabetes, and 13 non-diabetic controls. The authors discovered that the patients who were protected from advanced DR had higher levels of RBP3, a protein secreted by light-sensing cells in the eyes. Injecting RBP3 into the eyes of mice protected the animals against induced DR, and analysis showed that the protein inhibited the harmful effects of the growth factor VEGF and curtailed the secretion of inflammatory molecules in retinal cells. Future work should aim to replicate these results in people with short-term T1D or type 2 diabetes, the authors say.
-end-


American Association for the Advancement of Science

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...